Cargando…
Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19
The ongoing outbreak of COVID-19 has quickly become a daunting challenge to global health. In the absence of targeted therapy and a reported 5.5% case fatality rate in the United States, treatments preventing rapid cardiopulmonary failure are urgently needed. Clinical features, pathology and homolog...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362842/ https://www.ncbi.nlm.nih.gov/pubmed/32681986 http://dx.doi.org/10.1016/j.niox.2020.07.003 |